181 related articles for article (PubMed ID: 8649830)
1. Evidence for GEAPS, novel Glial E2F1-Associated Proteins in hamster glioma cells induced by the human neurotropic polyomavirus, JCV.
Raj GV; Ansari SA; Khalili K
Oncogene; 1996 Mar; 12(6):1279-88. PubMed ID: 8649830
[TBL] [Abstract][Full Text] [Related]
2. The transcription factor E2F-1 modulates TGF-beta1 RNA expression in glial cells.
Thatikunta P; Raj GV; Kundu M; Khalili K; Amini S
Oncogene; 1997 Jun; 14(24):2959-69. PubMed ID: 9205103
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
Hiyama H; Iavarone A; Reeves SA
Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
[TBL] [Abstract][Full Text] [Related]
4. Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1.
Darbinian N; Gallia GL; Kundu M; Shcherbik N; Tretiakova A; Giordano A; Khalili K
Oncogene; 1999 Nov; 18(46):6398-402. PubMed ID: 10597240
[TBL] [Abstract][Full Text] [Related]
5. Dual mechanisms of repression of E2F1 activity by the retinoblastoma gene product.
Zacksenhaus E; Jiang Z; Phillips RA; Gallie BL
EMBO J; 1996 Nov; 15(21):5917-27. PubMed ID: 8918469
[TBL] [Abstract][Full Text] [Related]
6. Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F.
Ohtani K; Iwanaga R; Nakamura M; Ikeda M; Yabuta N; Tsuruga H; Nojima H
Oncogene; 1999 Apr; 18(14):2299-309. PubMed ID: 10327050
[TBL] [Abstract][Full Text] [Related]
7. Regulation of dihydrofolate reductase gene expression and E2F components in human diploid fibroblasts during growth and senescence.
Good L; Dimri GP; Campisi J; Chen KY
J Cell Physiol; 1996 Sep; 168(3):580-8. PubMed ID: 8816912
[TBL] [Abstract][Full Text] [Related]
8. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
O'Connor RJ; Schaley JE; Feeney G; Hearing P
Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
[TBL] [Abstract][Full Text] [Related]
9. Expression of a deletion mutant of the E2F1 transcription factor in fibroblasts lengthens S phase and increases sensitivity to S phase-specific toxins.
Logan TJ; Evans DL; Mercer WE; Bjornsti MA; Hall DJ
Cancer Res; 1995 Jul; 55(13):2883-91. PubMed ID: 7540951
[TBL] [Abstract][Full Text] [Related]
10. A comparison of DNA-binding drugs as inhibitors of E2F1- and Sp1-DNA complexes and associated gene expression.
Chiang SY; Azizkhan JC; Beerman TA
Biochemistry; 1998 Mar; 37(9):3109-15. PubMed ID: 9485464
[TBL] [Abstract][Full Text] [Related]
11. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
Araki K; Nakajima Y; Eto K; Ikeda MA
Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
[TBL] [Abstract][Full Text] [Related]
12. Changes in E2F DNA-binding activity during induced erythroid differentiation.
Richon VM; Venta-Perez G
Cell Growth Differ; 1996 Jan; 7(1):31-42. PubMed ID: 8788031
[TBL] [Abstract][Full Text] [Related]
13. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
14. The helix-loop-helix protein Id-1 and a retinoblastoma protein binding mutant of SV40 T antigen synergize to reactivate DNA synthesis in senescent human fibroblasts.
Hara E; Uzman JA; Dimri GP; Nehlin JO; Testori A; Campisi J
Dev Genet; 1996; 18(2):161-72. PubMed ID: 8934878
[TBL] [Abstract][Full Text] [Related]
15. Glial cells of the human developing brain and B cells of the immune system share a common DNA binding factor for recognition of the regulatory sequences of the human polyomavirus, JCV.
Major EO; Amemiya K; Elder G; Houff SA
J Neurosci Res; 1990 Dec; 27(4):461-71. PubMed ID: 1964178
[TBL] [Abstract][Full Text] [Related]
16. E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription.
Cartwright P; Müller H; Wagener C; Holm K; Helin K
Oncogene; 1998 Aug; 17(5):611-23. PubMed ID: 9704927
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an E2F-p130 complex formed during growth arrest.
Corbeil HB; Branton PE
Oncogene; 1997 Aug; 15(6):657-68. PubMed ID: 9264406
[TBL] [Abstract][Full Text] [Related]
18. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
Rotheneder H; Geymayer S; Haidweger E
J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
[TBL] [Abstract][Full Text] [Related]
19. Reduction in fibronectin expression and alteration in cell morphology are coincident in NIH3T3 cells expressing a mutant E2F1 transcription factor.
Jordan-Sciutto KL; Logan TJ; Norton PA; Derfoul A; Dodge GR; Hall DJ
Exp Cell Res; 1997 Nov; 236(2):527-36. PubMed ID: 9367638
[TBL] [Abstract][Full Text] [Related]
20. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters.
Robertson KD; Ait-Si-Ali S; Yokochi T; Wade PA; Jones PL; Wolffe AP
Nat Genet; 2000 Jul; 25(3):338-42. PubMed ID: 10888886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]